Home › Kanser sa Ovary › Nebraska › Omaha

Pag-aaral pangklinika para sa Kanser sa Ovary sa Omaha, NE

14 pag-aaral para sa Kanser sa Ovary ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Omaha (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Nebraska Cancer Specialists, Omaha
XCancer, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07189871

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

Nagre-recruitPhase 1

University Of Nebraska Medical Center /ID# 281020, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07278336

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Nagre-recruitPhase 1/2

University of Nebraska Medical Center, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06799065

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Nagre-recruitPhase 3

Nebraska Methodist Hospital ( Site 0004), Omaha
University Of Nebraska Medical Center ( Site 0035), Omaha

Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT07318558

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Nagre-recruitPhase 1/2

Nebraska Cancer Specialists, Omaha

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07109726

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Nagre-recruitPhase 2

Nebraska Methodist Hospital, Omaha

Edad 18 hanggang 99 · Kababaihan · Na-update Set 15, 2026 · NCT07023627

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Nagre-recruitPhase 3

Nebraska Methodist Hospital ( Site 0053), Omaha

Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06824467

Study of NTB-928 in R/R OC

Nagre-recruitPhase 1

University of Nebraska Medical Center, Omaha

Edad 18 pataas · Kababaihan · Na-update Ago 20, 2026 · NCT07690189

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Nagre-recruit

Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
Nebraska Methodist Hospital, Omaha
Nebraska Medicine-Village Pointe, Omaha
at 4 pa

Edad 35 hanggang 50 · Kababaihan · Na-update Ago 7, 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Nagre-recruitPhase 3

Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
Nebraska Methodist Hospital, Omaha
Nebraska Medicine-Village Pointe, Omaha
at 8 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06580314

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Nagre-recruitPhase 2

Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha

Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Nagre-recruitPhase 1/2

Nebraska Cancer Specialists, Omaha

Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06710756

Integrated Cancer Repository for Cancer Research

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Methodist Estabrook Cancer Center, Omaha
Nebraska Methodist Health System, Omaha
University of Nebraska Medical Center, Omaha
at 1 pa

Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Omaha

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser sa Ovary sa ibang lungsod

Iba pang pag-aaral sa Omaha

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.